SMARCA1 and neoplasm: The tumor-suppressive function of the SWI/SNF chromatin remodeling complex has been recognized in cancers, including ovarian clear cell carcinoma, clear-cell renal cell carcinoma, hepatocellular carcinoma (HCC), gastric cancer, and pancreatic cancer [62].